| Literature DB >> 25407319 |
Jorge Lepikson-Neto, Leandro C Nascimento, Marcela M Salazar, Eduardo L O Camargo, João P F Cairo, Paulo J Teixeira, Wesley L Marques, Fabio M Squina, Piotr Mieczkowski, Ana C Deckmann, Gonçalo A G Pereira.
Abstract
BACKGROUND: Eucalyptus species are the most widely planted hardwood species in the world and are renowned for their rapid growth and adaptability. In Brazil, one of the most widely grown Eucalyptus cultivars is the fast-growing Eucalyptus urophylla x Eucalyptus grandis hybrid. In a previous study, we described a chemical characterization of these hybrids when subjected to flavonoid supplementation on 2 distinct timetables, and our results revealed marked differences between the wood composition of the treated and untreated trees.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25407319 PMCID: PMC4248463 DOI: 10.1186/s12870-014-0301-8
Source DB: PubMed Journal: BMC Plant Biol ISSN: 1471-2229 Impact factor: 4.215
Figure 1Heat map clustering and Venn diagram of differentially expressed genes. A) Heat map clustering of differentially expressed transcripts and comparison of the estimated log2 fold change correlations between each group subjected to differential expression analyses. B) Venn diagram of differentially expressed genes. CH- prolonged narigenin-chalcone supp; NAR – prolonged naringenin supp; CHSTOP- short-term naringenin-chalcone supp; NARSTOP – short-termnaringenin sup.
Gene ID, FPKM values and annotation of the 36 genes that found to be differentially expressed in all tested conditions
|
| ||||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| Eucgr.F04479.1 | HSP20 | 0.12 | 35.55 | 40.44 | 23.84 | 57.92 |
| Eucgr.K02389.1 | Unknown | 0.04 | 13.69 | 10.18 | 9.89 | 26.99 |
| Eucgr.K02399.1 | Unknown | 0.08 | 18.09 | 18.67 | 19.48 | 53.82 |
| Eucgr.G01188.2 | EGY3 | 2.78 | 45.78 | 41.56 | 33.40 | 76.35 |
| Eucgr.J01979.1 | HSP18.2 | 0.34 | 17.61 | 19.94 | 14.63 | 27.21 |
| Eucgr.K02410.1 | Unknown | 0.13 | 14.27 | 10.66 | 12.52 | 29.61 |
| Eucgr.J01980.1 | HSP18.2 | 0.02 | 12.20 | 11.59 | 9.15 | 26.39 |
| Eucgr.L02233.1 | no hit | 1.29 | 41.47 | 38.15 | 29.24 | 118.40 |
| Eucgr.F02898.1 | HSP20 | 2.76 | 525.99 | 343.17 | 280.68 | 342.59 |
| Eucgr.J01985.1 | HSP18.2 | 0.31 | 22.25 | 16.62 | 13.21 | 33.33 |
| Eucgr.K03553.1 | STS | 0.04 | 4.11 | 4.59 | 2.83 | 6.87 |
| Eucgr.L03261.1 | HSP18.2 | 1.44 | 47.41 | 27.81 | 19,98 | 75,67 |
| Eucgr.C03449.1 | HSFA2 | 0.29 | 14.55 | 12.98 | 14.36 | 18.58 |
| Eucgr.C00684.1 | HSP17.6II | 2.00 | 341.30 | 299.30 | 243.65 | 272.90 |
| Eucgr.K02384.1 | unknown | 0.07 | 14.56 | 10.59 | 10.60 | 27.23 |
| Eucgr.J01969.1 | HSP20 | 4.89 | 192.23 | 134.53 | 103.09 | 310.44 |
| Eucgr.K03472.1 | ARATH | 0.07 | 109.57 | 84.15 | 62.04 | 20.94 |
| Eucgr.H04513.1 | HSP70 | 0.23 | 15.72 | 18.79 | 11.56 | 21.62 |
| Eucgr.A00595.1 | PEBP | 0.10 | 81.17 | 76.66 | 57.33 | 98.83 |
| Eucgr.E02421.1 | Unknown | 0.19 | 260.04 | 220.12 | 119.63 | 51.05 |
| Eucgr.H04692.1 | HSP21 | 2.97 | 83.31 | 59.57 | 43.11 | 313.22 |
| Eucgr.G02440.1 | UGT73B2 | 0.00 | 5.46 | 5.80 | 3.33 | 4.06 |
| Eucgr.G02259.1 | UGT73B3 | 0.00 | 2.73 | 2.14 | 1.18 | 3.10 |
| Eucgr.J01959.1 | HSP18.2 | 3.19 | 142.90 | 89.76 | 58.22 | 148.21 |
| Eucgr.K00295.1 | HSP90.1 | 2.11 | 46.13 | 38.25 | 35.52 | 62.69 |
| Eucgr.A01833.1 | AAC3 | 0.13 | 32.00 | 24.43 | 15.08 | 10.47 |
| Eucgr.C03071.1 | HSP17.6II | 3.64 | 517.08 | 509.51 | 451.66 | 324.54 |
| Eucgr.B03843.1 | No hit | 1.45 | 93.17 | 63.39 | 67.61 | 20.77 |
| Eucgr.C03320.1 | DUF1677 | 0.38 | 24.39 | 18.22 | 14.01 | 9.78 |
| Eucgr.B00176.2 | PIMT2 | 3.86 | 153.25 | 109.01 | 82.97 | 57.39 |
| Eucgr.J02588.1 | No hit | 3.20 | 225.90 | 182.76 | 194.01 | 130.04 |
| Eucgr.C00690.1 | HSP17.6II | 2.48 | 563.68 | 498.40 | 514.67 | 458.94 |
| Eucgr.K00237.1 | PEBP | 0.04 | 115.83 | 64.41 | 61.47 | 11.49 |
| Eucgr.F03196.1 | GSTU25 | 1.43 | 292.73 | 240.63 | 168.71 | 38.29 |
| Eucgr.I02136.1 | HSP20 | 1.68 | 226.73 | 147.43 | 90.02 | 259.35 |
| Eucgr.H04427.1 | MEE32 | 49.92 | 0.52 | 0.85 | 1.32 | 13.93 |
A total of 36 genes were differentially expressed in all four conditions. FPKM -fragments per kilobase of exon per million fragments mapped. CT – control; CH – prolonged naringenin-chalcone supp; NAR – prolonged naringenin supp; CHSTOP- short-term naringenin-chalcone supp; NARSTOP – short-term naringenin supp.
Abbreviations: HSP20 HSP20-like chaperone superfamily protein, unknown unknown protein, EGY3 ethylene-dependent gravitropism-deficient and yellow-green-like 3, HSP18.2 heat shock protein 18.2, HSP20 HSP20-like chaperones superfamily protein, STS stachyose synthase, HSFA2 heat shock transcription factor A2, HSP17.6II 17.6 kDa class II heat shock protein, ARATH Adenine nucleotide alpha hydrolases-like superfamily protein, HSP70 BIP1heat shock protein 70 family protein, PEBP phosphatidylethanolamine-binding protein family protein, HSP21 heat shock protein 21, UGT73B2 UDP-glucosyltransferase 73B2, UGT73B3UDP glucosyl transferase 73B3, HSP90.1 heat shock protein 90.1, AAC3 ADP/ATP carrier 3, DUF1677 protein of unknown function, PIMT2 protein-l-isoaspartate methyltransferase 2, GSTU25 glutathione S-transferase TAU 25, MEE32 dehydroquinate dehydratase, putative/shikimate dehydrogenase.
Figure 2GO analysis. Common GO categories that were enriched (p-values ≤0.05) between treatments. CH – prolonged naringenin-chalcone supp; NAR – prolonged naringenin supp; CHSTOP- short term naringenin-chalcone supp; NARSTOP – short-term naringenin supplementation.
Figure 3MapMan analysis. MapMan overview of the metabolism- and cellular response-related genes among the 1,573 genes that were differentially expressed under the four different flavonoid treatments. The presented values are the fold changes between the treatment and control groups. CH – prolonged naringenin-chalcone supp; NAR – prolonged naringenin supp; CHSTOP- short-term naringenin-chalcone supp; NARSTOP – short-term naringenin supp.
Differentially expressed phenylpropanoid-related genes
|
| ||||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| Eucgr.C00859.1 | U91A1 | 0.00 | 1.60* | 0.83 | 0.28 | 0.00 |
| Eucgr.K00903.1 | AAT | 0.38 | 3.91 | 4.61* | 3.45 | 1.26 |
| Eucgr.K00901.1 | AAT | 0.83 | 0.03* | 0.98 | 1.18 | 1.51 |
| Eucgr.E01250.1 | PRR1 | 38.77 | 3.72* | 4.68* | 7.66 | 21.15 |
| Eucgr.B03781.1 | AA | 24.04 | 0.04* | 0.86 | 1.39 | 9.77 |
| Eucgr.D02454.1 | DFR | 0.05 | 3.10* | 2.73* | 1.32 | 0.48 |
| Eucgr.G02325.1 | DFR | 2.51 | 28.24* | 20.16* | 21.06 | 9.55 |
| Eucgr.F04163.1 | LAC14 | 6.22 | 0.15 | 0.32* | 0.57 | 1.82 |
| Eucgr.F02646.1 | LAC14 | 1.99 | 0.00* | 0.02* | 0.06* | 0.44 |
| Eucgr.F04162.1 | LAC14 | 1.95 | 0.09 | 0.04* | 0.06 | 0.72 |
| Eucgr.H04937.1 | LAC14 | 13.67 | 0.02* | 0.15* | 0.21 | 4.66 |
| Eucgr.F04160.1 | LAC14 | 17.17 | 0.04* | 0.25* | 0.26* | 3.08 |
| Eucgr.F02674.1 | LAC14 | 7.13 | 0.28 | 0.27* | 0.42 | 2.90 |
| Eucgr.H04936.1 | LAC14 | 8.51 | 0.04* | 0.03* | 0.08 | 2.50 |
| Eucgr.B02796.1 | LAC4 | 12.04 | 0.28* | 1.95 | 3.31 | 5.69 |
| Eucgr.K00957.1 | ATOMT1 | 1.36 | 17.54 | 17.19* | 10.55 | 15.16 |
| Eucgr.A01877.1 | OMT-like | 0.00 | 0.31 | 0.79 | 1.75* | 0.22 |
| Eucgr.J00363.1 | HCT | 88.68 | 3.76* | 16.43 | 29.57 | 53.35 |
| Eucgr.B00137.1 | 4CL | 12.31 | 1.83 | 2.50* | 4.21 | 6.24 |
| Eucgr.E00270.1 | CCR | 30.29 | 3.21 | 3.29* | 4.03 | 8.00 |
| Eucgr.G01350.2 | CAD5 | 23.73 | 146.29* | 126.30* | 144.55 | 62.96 |
| Eucgr.E01110.2 | CAD1 | 4.34 | 59.21 | 49.17* | 51.45 | 27.12 |
FPKM -fragments per kilobase of exon per million fragments mapped. CT – control; CH – prolonged naringenin-chalcone supp; NAR – prolonged naringenin supp; CHSTOP- short-term naringenin-chalcone supp; NARSTOP – short-term naringenin sup *Denotes differential expression.
Abbreviations: U91A1 UDP-Glycosyltransferase superfamily protein, AAT HXXXD-type acyl-transferase family protein, PRR1 pinoresinol reductase, AA Plant L-ascorbate oxidase, DFR Dihydroflavonol-4-reductase, LAC14 laccase 14, LAC4 laccase 4, ATOMT1 O-methyltransferase 1, OMT-like O-methyltransferase family protein, HCT hydroxycinnamoyl-CoA shikimate transferase, 4 CL 4 coumarate CoA ligase, CCR cinnamoyl-CoA reductase, CAD cinnamyl alcohol dehydrogenase.
Differentially expressed secondary cell wall genes
|
| ||||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| Eucgr.C03199.1 | SUS4 | 1,532.75 | 66.91* | 100.38* | 132.04 | 213.15 |
| Eucgr.C01715.1 | SPS1F | 3.32 | 63.28* | 54.72 | 35.80* | 28.00 |
| Eucgr.F00464.1 | SUT4 | 28.18 | 85.70 | 85.04 | 82.49* | 36.89 |
| Eucgr.D01765.2 | CSLG3 | 0.07 | 3.26 | 6.28* | 7.07* | 1.24 |
| Eucgr.F04010.1 | CSLC05 | 7.51 | 0.11* | 0.35 | 0.47* | 3.06 |
| Eucgr.J00420.1 | CSLA2 | 41.08 | 2.63* | 5.07* | 5.87* | 25.59 |
| Eucgr.E00226.1 | CSLD3 | 10.13 | 0.53 | 0.78 | 0.68 | 2.11 |
| Eucgr.E00821.1 | CSLG2 | 3.07 | 0.38* | 0.35 | 0.78* | 3.03 |
| Eucgr.J02497.1 | AMR1 | 1.00 | 5.25 | 6.14 | 6.11* | 2.68 |
| Eucgr.J02407.1 | MUR1 | 74.28 | 18.89 | 17.82 | 19.95* | 38.28 |
| Eucgr.B03204.1 | MUR2 | 13.62 | 55.51 | 54.92 | 47.91* | 32.70 |
| Eucgr.J01663.1 | XTH5 | 97.41 | 1.21* | 1.87* | 3.31* | 75.71 |
| Eucgr.B03348.1 | XTH33 | 26.89 | 0.21 | 0.15* | 0.07* | 9.47 |
| Eucgr.K00883.2 | XTH9 | 607.60 | 16.06* | 29.74 | 37.61* | 288.85 |
| Eucgr.C00184.1 | XTH23 | 45.26 | 0.45 | 0.72* | 0.22* | 37.20 |
| Eucgr.H02634.1 | XTH16 | 386.73 | 21.78* | 47.14 | 72.69 | 396.09 |
| Eucgr.D01294.1 | XTH8 | 10.82 | 1.01 | 1.54 | 1.66* | 7.36 |
| Eucgr.J00827.1 | GSL12 | 0.04 | 0.90* | 1.56* | 0.98* | 0.76* |
| Eucgr.A02002.1 | GSL7 | 0.20 | 1.24 | 2.13 | 1.38* | 0.79 |
| Eucgr.A02008.1 | GSL7 | 0.16 | 1.07 | 1.89 | 1.66* | 0.83 |
| Eucgr.K02988.2 | GH | 16.20 | 90.51* | 69.09* | 53.94 | 47.27* |
| Eucgr.H00494.1 | PWD | 6.13 | 20.24 | 26.24* | 27.22 | 7.21 |
| Eucgr.H03767.1 | BAM9 | 39.25 | 225.21 | 235.09* | 217.12 | 115.07 |
| Eucgr.E00460.1 | TPS | 0.08 | 5.75* | 6.21* | 4.26 | 0.34 |
| Eucgr.K00387.1 | SS | 9.88 | 66.76* | 54.46* | 39.19 | 19.93 |
| Eucgr.C04266.1 | RafS | 26.09 | 1,317.97* | 1007.17 | 544.49 | 193.24 |
| Eucgr.K03553.1 | STS | 0.04 | 4.11* | 4.59* | 2.83* | 6.87* |
| Eucgr.H00997.1 | STS | 0.81 | 37.45* | 29.83* | 17.09* | 7.06* |
| Eucgr.K03563.1 | GoSL1 | 0.23 | 4.48 | 11.12* | 12.00 | 8.48* |
| Eucgr.L00249.1 | GoSL2 | 0.34 | 280.16* | 135.36* | 52.37* | 1.25 |
| Eucgr.L00243.1 | GoSL2 | 0.02 | 29.83* | 19.77* | 9.75* | 1.37* |
| Eucgr.L00251.1 | GoSL2 | 0.21 | 325.56* | 149.21* | 61.46* | 3.38 |
| Eucgr.L03245.1 | GoSL2 | 0.07 | 190.81* | 124.71* | 44.86* | 2.79* |
| Eucgr.L00240.1 | GoSL2 | 0.02 | 34.50* | 22.77* | 10.27* | 0.66 |
| Eucgr.L00248.1 | GoSL2 | 0.17 | 162.07* | 86.93* | 32.28* | 0.69 |
| Eucgr.L03244.1 | GoSL2 | 0.12 | 279.83* | 137.40* | 63.66* | 2.99* |
| Eucgr.L00235.1 | GoSL2 | 0.04 | 73.19* | 38.88* | 15.60* | 0.03 |
| Eucgr.L00245.1 | GoSL2 | 1.83 | 287.87* | 164.66 | 80.81* | 5.28 |
| Eucgr.F01661.1 | Invertase | 0.15 | 2.82* | 2.16 | 2.39* | 1.33 |
| Eucgr.J00457.2 | Invertase | 5.69 | 47.20* | 42.83 | 33.08* | 18.78 |
| Eucgr.G01751.1 | Invertase | 4.83 | 0.23* | 0.42 | 1.17* | 2.23 |
| Eucgr.A02888.1 | Invertase | 7.36 | 0.04* | 0.08* | 0.08* | 1.55 |
FPKM -fragments per kilobase of exon per million fragments mapped. CT – control; CH – prolonged naringenin-chalcone supp; NAR – prolonged naringenin supp; CHSTOP- short-term naringenin-chalcone supp; NARSTOP – short-term naringenin sup *Denotes differential expression.
Abbreviations: Sus4 sucrose synthase 4, SPS1F sucrose phosphate synthase 1 F, SUT4 sucrose transporter 4, CSLG3 cellulose synthase like G3, CSLD3 cellulose synthase-like D3, CSLC05 Cellulose-synthase-like C5, CSLA2 cellulose synthase-like A02, CSLG2 cellulose synthase like G2, CSLG3 cellulose synthase like G3, CESA3 cellulose synthase family protein, AMR1 ascorbic acid mannose pathway regulator 1, MUR1 GDP-mannose 4,6 dehydratase 2, MUR2 fucosyltransferase 1, XTH5 xyloglucan endotransglucosylase/hydrolase 5, XTH33 xyloglucosyl transferase 33, XTH9 xyloglucan endotransglucosylase/hydrolase 9, XTH23 xyloglucan endotransglycosylase 6, XTH16 xyloglucan endotransglucosylase/hydrolase 16, XTH8 xyloglucan endotransglucosylase/hydrolase 8, GSL12 glucan synthase-like 12, GSL7 glucan synthase-like 7, GH glycoside hydrolase, PWD phosphoglucan water dikinases, BAM9 beta-amylase 9, TPS trehalose-6-phosphate synthase, SS starch synthase, Rafs raafinose synthase, STS stachyose synthase, GoSL1 galactinol synthase 1, GoSL2 galactinol synthase 2.
Differentially expressed stress-related genes
|
| ||||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| Eucgr.H05081.4 | ALDH3I1 | 4.84 | 0.93* | 1.11* | 1.60 | 5.34 |
| Eucgr.C00112.1 | CIA2 | 0.70 | 12.29* | 14.05* | 17.42* | 3.57 |
| Eucgr.K01387.2 | COL9 | 3.33 | 26.78* | 22.63* | 18.02* | 2.56 |
| Eucgr.C03449.1 | HSFA2 | 0.29 | 14.55* | 12.98* | 14.36* | 18.58* |
| Eucgr.C03456.1 | HSFA2 | 0.09 | 2.67* | 3.64* | 2.25* | 1.45 |
| Eucgr.C00873.1 | HSFA2 | 1.92 | 24.38* | 18.82* | 14.75* | 7.94 |
| Eucgr.C03434.1 | HSFA2 | 0.31 | 6.75* | 6.22* | 6.19* | 2.03 |
| Eucgr.C01043.1 | HSFC1 | 2.92 | 122.26* | 116.87* | 96.98* | 13.96 |
| Eucgr.J01981.1 | HSP18.2 | 2.00 | 34.43 | 50.34 | 69.86* | 105.48* |
| Eucgr.J01980.1 | HSP18.2 | 0.02 | 12.20* | 11.59* | 9.15* | 26.39* |
| Eucgr.J01959.1 | HSP18.2 | 3.19 | 142.90* | 89.76* | 58.22* | 148.21* |
| Eucgr.J01958.1 | HSP18.2 | 2.68 | 115.32* | 90.34* | 65.56 | 100.03 |
| Eucgr.J01979.1 | HSP18.2 | 0.34 | 17.61* | 19.94* | 14.63* | 27.21* |
| Eucgr.J01958.1 | HSP18.2 | 2.68 | 115.32* | 90.34* | 65.56 | 100.03 |
| Eucgr.J01979.1 | HSP18.2 | 0.34 | 17.61* | 19.94* | 14.63* | 27.21* |
| Eucgr.J01977.1 | HSP18.2 | 0.37 | 9.43* | 8.59* | 7.08 | 19.26* |
| Eucgr.J01964.1 | HSP18.2 | 13.65 | 145.21* | 119.05* | 111.04 | 251.88* |
| Eucgr.J01985.1 | HSP18.2 | 0.31 | 22.25* | 16.62* | 13.21* | 33.33* |
| Eucgr.J01982.1 | HSP18.2 | 0.21 | 8.65* | 6.06* | 4.24 | 13.03* |
| Eucgr.F04479.1 | HSP20-like | 0.12 | 35.55* | 40.44* | 23.84* | 57.92* |
| Eucgr.I02136.1 | HSP20-like | 1.68 | 226.73* | 147.43* | 90.02* | 259.35* |
| Eucgr.J01969.1 | HSP20-like | 4.89 | 192.23* | 134.53* | 103.09* | 310.44* |
| Eucgr.G00061.1 | HSP20-like | 9.45 | 834.94* | 858.21* | 726.74* | 814.87 |
| Eucgr.E00433.1 | HSP20-like | 3.35 | 295.94 | 205.55* | 185.03 | 165.89 |
| Eucgr.F02898.1 | HSP20-like | 2.76 | 525.99* | 343.17* | 280.68* | 342.59* |
| Eucgr.A01416.1 | HSP21 | 0.08 | 12.40* | 7.60* | 4.34* | 0.29 |
| Eucgr.H04692.1 | HSP21 | 2.97 | 83.31* | 59.57* | 43.11* | 313.22* |
| Eucgr.J03127.1 | Hsp70b | 8.27 | 1576.75 | 1347.55* | 881.92 | 925.42 |
| Eucgr.H03518.1 | HSP70T-2 | 6.06 | 282.04* | 218.12* | 152.91 | 249.47 |
| Eucgr.K00295.1 | HSP90-1 | 2.11 | 46.13* | 38.25 | 35.52* | 62.69* |
| Eucgr.F03704.1 | MSL6 | 1.45 | 27.74 | 21.67* | 11.53* | 10.03 |
| Eucgr.H02896.1 | MYB305 | 0.07 | 6.57* | 8.20* | 6.34* | 1.14 |
| Eucgr.C00618.1 | Oleosin | 0.50 | 38.75* | 24.66* | 18.36* | 2.85 |
| Eucgr.F01003.1 | PAT1 | 2.30 | 43.54* | 47.40* | 43.89* | 6.02 |
| Eucgr.K00237.1 | PEBP | 0.04 | 115.83* | 64.41* | 61.47* | 11.49* |
| Eucgr.B00176.2 | PIMT2 | 3.86 | 153.25* | 109.01* | 82.97* | 57.39* |
| Eucgr.G01510.1 | RLK | 1.71 | 10.40* | 11.17* | 11.20* | 6.80 |
| Eucgr.F01854.1 | TRX1 | 4.16 | 598.03* | 295.93* | 191.61* | 25.01 |
| Eucgr.G02440.1 | UGT73B2 | 0.00 | 5.46* | 5.80* | 3.33* | 4.06* |
| Eucgr.L03261.1 | UGT73B3 | 1.44 | 47.41* | 27.81* | 19.98* | 75.67* |
| Eucgr.G02259.1 | UGT73B3 | 0.00 | 2.73* | 2.14* | 1.18* | 3.10* |
| Eucgr.I00409.1 | UGT73B3 | 0.06 | 3.27* | 4.18* | 2.91* | 0.60 |
| Eucgr.B02291.1 | UGT76E11 | 10.86 | 52.79* | 42.69* | 39.45 | 45.69 |
| Eucgr.K01389.2 | XERICO | 19.81 | 1,348.64* | 796.35* | 569.70* | 120.14 |
FPKM -fragments per kilobase of exon per million fragments mapped. CT – control; CH – prolonged naringenin-chalcone supp; NAR – prolonged naringenin supp; CHSTOP- short-term naringenin-chalcone supp; NARSTOP – short-term naringenin sup *Denotes differential expression.
Abbreviations: ALDH3I1 –aldehyde dehydrogenase 3I1, CIA2 chloroplast import apparatus 2, COL9 CONSTANS-like 9, HSFA2 heat shock transcription factor A2, HSFC1 heat shock transcription factor C1, HSP18.2 heat shock protein 18.2, HSP20 like chaperones superfamily protein, HSP21 heat shock protein 21, Hsp70b heat shock protein 70B, HSP70T-2 heat-shock protein 70 T-2, HSP90.1 heat shock protein 90.1, MSL6 mechanosensitive channel of small conductance-like 6, MYB305 myb domain protein 305, Oleosin family protein; PAT1 GRAS family transcription factor, PEBP –phosphatidylethanolamine-binding protein family protein, RLK receptor lectin kinase, TRX1 thioredoxin H-type 1, UGT73B2 UDP-glucosyltransferase 73B2, UGT73B3 UDP-glucosyl transferase 73B3, UGT76E11 UDP-glucosyl transferase 76E11, XERICO RING/U-box superfamily protein.
Total sugar and glucose values
|
|
|
|
| |
|---|---|---|---|---|
| CT | 7 | 1.17 (0.67) | 5.69 (3.23) | 0.39 (0.23) |
| CH | 4 | 1.8 (0.33) | 9.06 (1.83) | 0.56 (0.07) |
| NAR | 3 | 2.54 (0.005)** | 12.72 (0.66)** | 0.87 (0.10)** |
| CHSTOP | 3 | 2.32 (0.24)* | 11.81 (1.08)* | 0.85 (0.29)* |
| NARSTOP | 3 | 3 (0.85)** | 14.59 (4.34)** | 0.99 (0.09)** |
Mean values and standard deviations (parentheses) for total sugar and glucose levels. n –number of biological replicates; CT – control; CH – prolonged naringenin-chalcone supp; NAR – prolonged naringenin supp; CHSTOP –short-term naringenin-chalcone supp; NARSTOP – short-term naringenin supp. *p-value <0.05; **p-value <0.01.
Figure 4Effects of flanonoid supplementantion on secondary cell wall related genes. The effects of flavonoid supplementation on the expression of secondary cell wall-related genes. Sus –sucrose synthase; SPS –sucrose phosphate synthase; CesA –cellulose synthase;; GH –glycoside hydrolase; PWD –phosphoglucan water dikinases; BAM –beta-amylase; TPS –trehalose-6-phosphate synthase; SS –starch synthase; Rafs – raafinose synthase; STS –stachyose synthase; GoSL –galactinol synthase.